Appoints Lloyd Klickstein as Scientific Advisor for Immunology
Klickstein is CEO of Koslapp Therapeutics and co-founded Versanis Bio, which was acquired by Eli Lilly. - He previously held roles at Adicet Bio, resTORbio, Blade Therapeutics and Novartis, and was a physician-scientist at Harvard Medical School's Brigham and Women's Hospital.